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Abstract
Polo-like kinases (Plks) are a family of conserved regulators of a variety of events throughout the cell cycle, expanded from
one Plk in yeast to five Plks in mammals (Plk1-5). Plk1 is the best characterized member of the Plk family, homolog to the
founding member Polo of Drosophila, and plays a major role in cell cycle progression by triggering G2/M transition. Plk4/Sak
(for Snk (Serum-inducible kinase) akin kinase) is a unique member of the family, structurally distinct from other Plk
members, with essential functions in centriole duplication. The genome of the trematode parasite Schistosoma mansoni
contains only two Plk genes encoding SmPlk1 and SmSak. SmPlk1 has been shown already to be required for
gametogenesis and parasite reproduction. In this work, in situ hybridization indicated that the structurally conserved Plk4
protein, SmSak, was largely expressed in schistosome female ovary and vitellarium. Expression of SmSak in Xenopus oocytes
confirmed its Plk4 conserved function in centriole amplification. Moreover, analysis of the function of SmSak in meiosis
progression of G2-blocked Xenopus oocytes indicated that, in contrast to SmPlk1, SmSak cannot induce G2/M transition in
the absence of endogenous Plk1 (Plx1). Unexpectedly, meiosis progression was spontaneously observed in Plx1-depleted
oocytes co-expressing SmSak and SmPlk1. Molecular interaction between SmSak and SmPlk1 was confirmed by co-
immunoprecipitation of both proteins. These data indicate that Plk1 and Plk4 proteins have the potential to interact and
cross-activate in cells, thus attributing for the first time a potential role of Plk4 proteins in meiosis/mitosis entry. This
unexpected role of SmSak in meiosis could be relevant to further consider the function of this novel Plk in schistosome
reproduction.
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Introduction
Polo-like kinases (Plks) are important regulators of the cell cycle
progression during M-phase, primarily involved in the assembly
and dynamics of the mitotic spindle apparatus and in the
regulation of the activation of cyclin-dependent protein kinases
(Cdks) [1,2]. Plks are found in all eukaryotic lineages other than
plants and apicomplexans and form a family of serine/threonine
(S/T) kinases with conserved cellular functions. Metazoans possess
multiple Plks which have different functions but a common
structure composed of a conserved amino-terminal S/T kinase
domain and a carboxy-terminal Polo-box domain (PBD) respon-
sible for protein-protein interactions and subcellular localization
[3]. Five Plks (Plk1-5) are present in vertebrates [4].
Plk1-2-3 have similar structures with two conserved polo
boxes that can dimerise intramolecularly and form a pocket for
binding to phospho S/T residues (inside of the S-pS/pT-P-X
sequence) inducing conformational changes and kinase activa-
tion [5,6]. Plk1 is the best characterized member of the Plk
family. It is homologous to Polo, the first Plk member
discovered in Drosophila [7]. Plk1 participates in multiple
functions in mitosis, including centrosome maturation, kineto-
chore–spindle attachment, chromosome segregation and cytoki-
nesis. Over-expressed during late G2 and M phases, Plk1 is a
key inducer of mitosis and meiosis [3,8], and it already
constitutes a validated target for anti-cancer therapy [9,10]. In
contrast to Plk1, Plk2 is expressed primarily in G1 phase and
may control S phase entry, and Plk3 which is expressed at a
constant level throughout the cell cycle is involved in different
stress-response pathways. The roles of Plk2 (also named Snk for
Serum inducible kinase) and Plk3 (Fnk for FGF-inducible
kinase) are not completely understood [4].
Plk4 (also named Sak for Snk/Plk-akin kinase) is a divergent and
unique member of the Plk family [11–13]. Its PBD contains only
one polo box, suggesting that regulation and substrate repertoire of
Plk4 are different from those of other Plks [8,14]. During the cell
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at G2/M. Plk4 has a well-established function in centriole
duplication [15,16], but the recent discovery that Plk4 is involved
in regulating cytokinetic exit broadens the role of this kinase in
centrosome maturation and mitotic progression [17]. Its turnover
must be strictly controlled, and this is achieved by an autoregu-
latory mechanism implying its autophosphorylation in PEST
sequence, a recognition peptide for degradation by the proteasome
[18,19].
More recently, a fifth Plk family member, Plk5, has been
identified in vertebrates. Mouse Plk5 has been shown to be
inducible by stress as well as DNA damage, and it is localized in
the nucleolus [20]. In humans, Plk5 is kinase-deficient and seems
to have no role in cell cycle progression but specific functions in
neuron differentiation and activity in tumor suppression [21].
In invertebrates, like the insect Drosophila or the nematode
Caenorhabditis elegans, Plk genes belonging to the Plk1 and Plk4
subfamilies have been identified but no other Plk genes have been
found. In the genome of the human platyhelminth parasite
Schistosoma mansoni, we have found two genes, which similarly to
other invertebrates, are orthologs of Plk1 and Plk4, the latter one
was named SmSak [22]. SmPlk1 is a protein homologous to other
Plk1 members with conserved functions in mitotic processes [23].
SmPlk1 is abundantly transcribed in parasite gonads and the
dramatic alteration of schistosome gonads caused by the kinase
inhibitor specific for Plk1, BI2536 [9] suggested that SmPlk1
played a crucial role in gametogenesis and parasite reproduction
[23].
This paper presents the structure of the SmSak gene and
functional analyses of the SmSak protein. We analysed its
expression in the different stages of the parasite and found a
concentration of transcripts in female ovary and vitellarium. The
expression of SmSak in the model of Xenopus oocytes confirmed its
Plk4 conserved function in centriole amplification. Furthermore,
comparative studies of the functions of SmSak and SmPlk1 in
meiosis progression indicated that in contrast to SmPlk1 [23],
SmSak could not trigger directly G2/M transition in G2-blocked
Xenopus oocytes. Interestingly, we discovered that SmPlk1 and
SmSak proteins, directly interact and crossactivate each other
inducing kinase activity responsible for spontaneous meiosis
resumption in G2-blocked oocytes. These data indicated for the
first time that Plk1 and Plk4 proteins are able to cooperatively
contribute to meiosis/mitosis entry, which attributes a novel role
to Plk4 proteins.
Results
Molecular Cloning of SmSak
S. mansoni genome annotation [24] led to the identification of a
sequence putatively encoding a protein kinase similar to Sak
proteins (Genbank XP_002579066). In order to confirm the
sequence, we cloned by RT-PCR amplification of adult worm
RNA, the cDNA of SmSak (Genbank GU084154) from start to
stop codons. The full-length sequence contains an open reading
frame of 2712 bp coding for a protein of 903 residues with a
calculated molecular mass of 101.6 kDa.
Screening of the S. mansoni genome database (www.schistodb.
net) with the SmSak cDNA sequence indicated that SmSak was
present as a single copy in the genome, found on the chromosome
1 (Smp_079410 identifier; Smp_scaffold 000292). The gene SmSak
extends over 13 kb and is composed of ten exons of variable size
ranging from 51 (exon 1) to 989 bp (exon 8). The size of introns
varies from 144 pb to 3591 pb. In common with most of the
schistosome genes characterized so far, all exon-intron junctions
obeyed the GT-AG rule. Further extensive genomic analyses
indicated that only two Plk genes were present in the S. mansoni
genome, encoding SmPlk1 (described in [23]) and SmSak
respectively.
Sequence and Structure of SmSak
Protein sequence alignment displayed that SmSak and SmPlk1
share only 17% identity along their whole sequences and 37%
identity in their kinase domains. Both proteins exhibit a conserved
Plk structure composed of an N-terminal catalytic domain and a
C-terminal PBD. The SmSak PBD is characteristic for Sak
proteins and formed by a large cryptic polo-box (cry-pb) and a
single polo-box (PB) domain instead of the tandem PB domains
that are present in SmPlk1 (Figure 1) as well as in Plk1-3 of other
species. Phylogenetic studies further confirmed that SmSak was a
novel schistosome Plk belonging to the Sak/Plk4 group of the Plk
family (Figure S1).
Blast analysis and sequence alignment of several Sak/Plk4
proteins (Figure S2) showed that the SmSak kinase domain
(residues 19–270) contains the eleven subdomains characteristic of
protein kinases, including SmPlk1 [23]. In subdomain I, the
unique ATP-binding site GxGxFA sequence, common to other
Plks, replaces the canonical GxGxxG motif present in the majority
of protein kinases. The sequence HRDLxLxN (subdomain VI) and
the typical motif GTPNYIxPE (subdomain VIII) which are
considered as strong indicators for S/T kinase activity [25] are
present in SmSak as well as in other Sak proteins. Moreover, the
T175 residue located inside of the catalytic T loop of Plks and
known to be the site of phosphorylation and kinase activation is
conserved in SmSak, similarly to other Sak/Plk4 kinases. Overall,
the kinase domain of SmSak showed greater identity to that of
Drosophila Sak, human and murine Plk4 and Plx4 of Xenopus (55–
57%) than to that of Polo kinases (SmPlk1, Polo, Plk1 and Cdc5)
(27 to 37% identity).
SmSak533–802 and SmSak807–896 sequences correspond to the
cry-pb and the PB of the protein, respectively (Figure 1). Both
regions show a limited level of identity with the homologous
domains found in other Sak/Plk4 proteins. The alignment of
Sak proteins indicated that only 15–18% of the residues
composing the cry-pb of SmSak are identical to other cry-pbs.
The SmSak807–896 sequence showed greater identity to PB of
human and murine Sak (25%) than to that of Drosophila (12%).
Sak-PB domains have been shown to form homodimers, and
the structure-based alignment of the PB sequences of diverse
members of the Plk family has allowed the identification of 16
conserved residues positioned at the dimer interface [14].
Within the SmSak protein, 11 of these amino-acids are strictly
conserved, suggesting that its PB domain can also dimerize (see
Figure S2). Sak proteins are known to display a short half-life
with PEST motifs governing their stability [11,19]. Sequence
analysis with ePESTfind (http://emboss.bioinformatics.nl/cgi-
bin/emboss/epestfind) detected a single PEST sequence in
SmSak located inside the PB at positions 853–866 (Figure 1).
Whereas the PEST sequence commonly found behind the
kinase domain of Sak proteins is not detectable in SmSak, the
degron motif (ie, the starting place for degradation) DSGxxT
occurring in this PEST sequence [19], seems to be conserved at
this position in the SmSak sequence with the motif D289SIxxT
(Figure S2). S290 and T294 residues are conserved. Their
phosphorylation is known to create a binding site for b-TrCP
(beta-transducin repeat containing), a component of the SCF
(Skp1-cullin-F-box)-b-TrCP ubiquitin ligase complex, allowing
the ubiquitination of Sak proteins [26,27].
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SmSak transcripts were quantified in the different life stages of
the parasite by quantitative RT-PCR and transcript levels were
compared to those of SmPlk1 for each stage. As it was already
shown for SmPlk1 [23], the expression of SmSak appeared to be
elevated in female worms and miracidia (Figure 2A). However,
SmSak transcription dramatically decreases following transforma-
tion of miracidia into sporocysts, whereas here the SmPlk1
transcript level remains to be stable [23]. SmPlk1 and SmSak genes
seem to be transcribed at similar levels in male worms whereas
SmSak appears to be less transcribed than SmPlk1 in female worms,
cercariae and miracidia (66%, 70% and 85% less respectively) but
more expressed than SmPlk1 in sporocysts and schistosomula (17
and 41% more respectively) (Figure 2B).
Detection of SmSak transcripts by in situ hybridization on adult
worm sections indicated that SmSak is predominantly expressed in
the ovary (mostly in the large ovocytes present in the mature part
of the ovary) and in the vitellarium of females (Figure 3A,C,E).
Although weakly, transcripts were also detected in the testicular
lobes of the male (Figure 3A). The lower detection of SmSak
transcripts in males than in females also correlates with the results
obtained from Q-PCR (Figure 2A).
Comparative Activities of S. mansoni Plks in Xenopus
Oocyte Maturation
The main function of Plk1 kinases is to trigger G2/M transition
in cells by activating Cdc25C phosphatase and by promoting the
translocation of MPF (Maturation Phase Factor) into the nucleus.
In Xenopus, evidence has been obtained that injection of cRNA
encoding an active form of Plx1 (Plk1 homolog) was sufficient to
initiate meiosis resumption in resting oocytes and to induce
dissolution of the nuclear membrane or germinal vesicle break-
down (GVBD) [28], demonstrating the decisive role played by
Plx1 in G2/M transition. Previous studies have shown that
schistosome SmPlk1 was efficiently expressed in Xenopus oocytes
and could trigger resumption of meiosis, bearing a function similar
to that of Plx1. Indeed, in Plx1-depleted oocytes, the expression of
SmPlk1 induced in the presence of the hormonal stimulus
progesterone (PG), Cdc25 phosphorylation and MPF activation,
leading to the entry in M phase and provoking germinal vesicle
breakdown (GVBD) [23]. To unravel a possible function of
SmSak, we have investigated its activity during Xenopus oocyte
maturation. Results in Figure 4A indicate that the injection of
cRNA encoding SmSak did not induce resumption of meiosis in
oocytes, but that the expression of SmSakT175D, a mutant of
SmSak in which the conserved residue T175 within the T-loop has
been changed to aspartate in order to mimick its phosphorylation,
induced spontaneously GVBD in unstimulated oocytes, with an
efficiency comparable to that of PG stimulation (see Figure 4B). In
these conditions, phosphorylations of Plx1 and of its substrate
Cdc25C, were detected by protein shift in SDS-PAGE. These
results confirmed that SmSakT175D is an active kinase and were in
agreement with previous observations that the expression of non-
regulated active kinases in oocytes consistently induced maturation
[23,29,30]. When similar assays were performed in the presence of
PG (Figure 4B), GVBD occurred in non-injected oocytes as well as
in oocytes expressing SmSak or the active mutant SmSakT175D.
The results also indicated that dead-kinase (SmSak
DK) or unpho-
sphorylable kinase (SmSakT175A) mutants of SmSak did not affect
Plx1 and Cdc25 phosphorylations or oocyte maturation induced
by PG, indicating that in contrast to SmPlk1
DK and SmPlk1T182V
[23], inactive SmSak mutants did not represent negative
competitors of Plx1. This result suggested that SmSak could not
rescue the lack of Plx1, which was further confirmed by the
demonstration that induction of GVBD by the constitutively active
SmSakT175D required the presence of endogenous Plx1 in
oocytes. Under the influence of injected anti-Plx1 antibodies,
SmSakT175D was no more able to induce GVBD in oocytes.
Additionally, we demonstrated that a minimal amount of
SmSakT175D protein (expressed from 60 ng but not from 10 ng
cRNA) was necessary to trigger mitotic entry (Figure 4C). A
comparison of the capacity of SmPlk1 and SmSak (both native or
constitutively active) to induce GVBD in normal versus Plx1-
depleted oocytes with or without addition of PG is presented in
Figure 4D. With PG, GVBD occurred in oocytes expressing either
native or active SmPlk1 and SmSak, but if the oocytes were Plx1-
depleted, maturation took place only in oocytes expressing SmPlk1
or SmPlk1T182D. In the absence of PG, active SmPlk1T182D and
SmSakT175D induced GVBD in normal oocytes but only
SmPlk1T182D could elicit maturation in Plx1-depleted oocytes.
These data confirm those presented in Figure 4C and in [23] and
Figure 1. Structure of SmPlk1 and SmSak proteins. Plk1 and Sak proteins possess an amino-terminal serine/threonine kinase domain and a
carboxy-terminal polo-box domain (PBD) that dictates the substrate specificity of the enzymes and regulates their function. Phosphorylation of a
specific threonine (T182 or T175 respectively in SmPlk1 or SmSak) in the T-loop activation domain determines the activity of the kinases. Plk1 PBD is
made up of two polo-boxes, PB1 and PB2, that form intramolecular heterodimers able to bind specific phospho-motifs. Binding to phosphosubstrates
induces conformational changes and the access of the catalytic domain to its substrates [5,6]. Both PB1(AA 386–453) and PB2 (AA 488–557) are
contained in the sequence of SmPlk1. Sak PBD contains only one C-terminal PB, and a larger cryptic polo-box (cry-pb) weakly homologous to PB and
unable to heterodimerize intramolecularly. However, PB from two Sak molecules can homodimerize and be involved in the regulation of the kinase
activity. SmSak possesses a cry-pb (AA 533–802) and one PB (AA 807–896) containing a PEST destruction motif (AA 853–866) implicated very likely in
the regulation of its turnover.
doi:10.1371/journal.pone.0040045.g001
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in cell cycle progression.
Role of SmSak in de novo Centriole Formation
Plk4 is known to regulate centriole biogenesis [16], and its
deregulation has been linked to tumor development [31].
Overexpression of Plk4 in human cells induced rapid formation
of multiple complete centrioles within a single S phase [32].
Moreover, Sak overexpression was reported to induce amplifica-
tion of centrioles in Drosophila embryos as well as their de novo
formation in unfertilized Drosophila eggs [33,34]. This process of de
novo centriole formation due to Plk4 overexpression has been also
demonstrated in vertebrates. Indeed, overexpression of Plx4, the
Xenopus homolog of human Plk4, was shown to induce de novo
centriole formation in activated Xenopus eggs, but not in immature
(stage VI) oocytes [35]. Activation of eggs was artificially induced
in vitro by the addition of the calcium ionophore A23187 to
matured oocytes. A23187 mimics the increase of intracellular
calcium level, which occurs soon after fertilization playing a crucial
role for sperm-induced egg activation in almost all species [36].
According to this, we decided to study the potential function of
SmSak on centriole duplication in matured Xenopus oocytes
(Figure 5). Following a protocol similar to that described before
[35], immature oocytes were injected with cRNA encoding SmSak
constructs and incubated with PG in order to induce their
maturation. Matured oocytes were then activated with calcium
ionophore A23187 and the surface morphology of oocytes was
monitored microscopically. Figure 5 shows that the expression of
SmSak did not elicit any phenotype in PG-stimulated oocytes
which underwent GVBD similarly to control oocytes and
produced eggs blocked at metaphase II of meiosis. However,
when these eggs were further activated with A23187, all the
oocytes expressing SmSak developed speckled-like pigmentation
on their surface within 2 h, whereas the surface of control (non-
injected) oocytes remained unchanged. Pigmented speckles did not
appear even after 2 h on the surface of eggs previously injected
Figure 2. Quantification of SmSak transcripts in the parasite stages. A. SmSak transcripts were quantified in the different stages of the
parasite S. mansoni (M, male; F, female; Mir, miracidia; Spo, sporocyst; Cer, cercaria; Sch, schistosomulum). Tubulin transcript level was used as internal
standard. For graphical representation of qPCR data, DCt values calculated for SmSak in each parasitic stage were compared to the DCt value
obtained for males using the deltadeltaCt (DDCt) method [65]. Values were normalized as fold-difference relative to males. Mean of three
determinations +/2 SD. B. SmSak/SmPlk1 ratios in each parasite stage. SmSak and SmPlk1 transcripts were both quantified in two independent cDNA
fractions prepared from each stage. In this case, SmPlk1 was used as a reference. Mean values of ratios +/2 SD are given.
doi:10.1371/journal.pone.0040045.g002
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was essential to induce the speckled phenotype. Moreover, the
results indicated that SmPlk1 expressing oocytes did not show
pigmentation under activation by A23187, demonstrating the
specific function of SmSak in this process (Figure 5).
Roles of Kinase and PBD Domains of Schistosome Plks in
Oocyte Maturation and Activation
To decipher the relative importance of kinase and PBD
structures of SmPlk1 and SmSak for their respective functions,
we have constructed two hybrid molecules composed of the kinase
domain of SmPlk1 with the PBD of SmSak (namely Kin1-PBD4)
and inversely of the kinase domain of SmSak with the PBD of
SmPlk1 (namely Kin4-PBD1) (Figures 1 and 6A) and we have
analyzed their activity in the process of oocyte activation described
previously. First, we observed that neither Kin1-PBD4, nor Kin4-
PBD1 were capable of generating the speckled phenotype
obtained in SmSak-expressing matured oocytes when they were
activated by A23187. This confirms the importance and the
specificity of both the kinase and the PBD domains of Sak for
centriole biogenesis [35] (Figure 5).
In contrast to SmPlk1, SmSak cannot restore the function of
Plx1 in Plx1-depleted oocytes (Figure 4D). However, the results
presented in Figure 6 clearly indicated that Kin4-PBD1 could
rescue, as SmPlk1 (Kin1-PBD1), the absence of Plx1 in oocytes
which underwent GVBD under PG stimulation, whereas this was
not observed for Kin1-PBD4 or SmSak (Kin4-PBD4). These data
confirmed that PBD1 was required for a Plk-dependent matura-
tion of oocytes. Furthermore, the use of constructs in which Kin1
and Kin4 originated from unphosphorylable SmPlk1T182V and
SmSakT175A demonstrated that the effect of Kin1-PBD1 and
Kin4-PBD1 in oocyte maturation was also dependent on their
kinase activities. Finally, these data showed that PBD1 was
specifically required for the activity of Plks in oocyte maturation
but they also indicated that both the SmPlk1 and the SmSak
kinase domains could be functional in this process.
Co-expression of SmPlk1 and SmSak is Sufficient to
Induce Oocyte Maturation
Results of in situ hybridization revealed a concentration of both
SmPlk1 and SmSak transcripts in the vitellarium as well as in the
oocytes present in the ovary of female schistosomes ([23] and
Figure 3). This finding prompted us to investigate the possibility
that SmPlk1 and SmSak might cooperate to regulate mitosis or
meiosis in parasite germinal cells. We have previously shown that
the expression of native SmSak (Figure 4 A, D) or SmPlk1 ([23],
Figure 4D) in immature Xenopus oocytes was not sufficient to
release their arrest in late G2 of meiosis I, but that these oocytes
were capable of responding to a PG stimulus and to undergo
GVBD, exactly as control oocytes. In this work, we have analyzed
the consequences of the simultaneous expression of SmSak and
SmPlk1 in such immature oocytes and discovered that GVBD
occurred in these conditions without addition of PG. This suggests
that an activation of at least one of the kinases had occurred,
which we assume to result from an interaction between both
parasite proteins. Co-immunoprecipitation experiments finally
confirmed the association between SmSak and SmPlk1 proteins
in oocytes which were injected with Myc-SmSak and V5-SmPlk1
constructs. Western blot analysis of proteins immunoprecipitated
from oocyte lysates using anti-Myc or anti-V5 antibodies
(Figure 7A) confirmed the correct expression of both proteins
and showed that SmPlk1 was present within the anti-Myc
immunoprecipitates and, inversely, that SmSak was present in
anti-V5 complexes. In order to determine which kinase(s) was
(were) responsible for GVBD, we tested unphosphorylable
SmSakT175A and SmPlk1T182V in co-expression experiments.
Results showed that the combination SmSakT175A/SmPlk1 was
ineffective, whereas GVBD occurred with the tandem SmSak/
SmPlk1T182V (Figure 7B). This indicated in this case that the
kinase activity of SmSak was required, but not that of SmPlk1, for
which deficient activity was probably rescued by that of
endogenous Plx1. This hypothesis could be finally verified by the
finding that maturation did not happen using SmSak/
SmPlk1T182V constructs injected into Plx1-depleted oocytes.
Additional experiments in which the hybrid constructs of SmPlk1
and SmSak (described in Figure 6A) were used, indicated that the
co-expression of Kin1-PBD4 and Kin4-PBD1 led to GVBD and
they also confirmed that both PBD1 and PBD4 were required for
the activation process (results not shown).
Discussion
Schistosoma is one of the most widespread human parasites, with
several hundred million people infected in many tropical and
subtropical countries [37,38]. The severity of schistosomiasis is
primarily due to the fecundity of the worms which develop in
human hosts. Mating and sexual maturation of adult male and
female S. mansoni in the host lead to the production of huge
numbers of fertilized eggs, which are for a large part released with
the feces, thus assuring active transmission. Besides, many eggs get
trapped in host tissues which are responsible for the formation of
inflammatory granulomas and for the pathology of schistosomiasis.
Chemotherapy still remains the most efficient approach to control
morbidity and mortality due to schistosomiasis and praziquantel
(PZQ) has been the drug of choice for several decades. However
prolonged and intensive use of PZQ in monotherapy has already
raised serious concerns about the development of resistance and
the necessity to discover novel targets and new drugs against
schistosomes [39,40]. Strategies for a reduction of parasite fertility
would constitute valuable approaches towards the control of both
transmission and pathology of the disease and in this context,
recent studies have been undertaken to decipher the molecular
mechanisms that regulate the development of sexual organs and
gamete production in S.mansoni [41–44]. Following the clear
demonstration that receptor tyrosine kinase signalling plays
essential functions in schistosome reproduction processes [43,44],
and that parasite-specific tyrosine kinases could already represent
novel interesting drug targets [29,30,44–45], we have further
considered the importance of the mitotic kinases, Plks, in the
regulation of cell cycle progression during schistosome reproduc-
tion processes. S mansoni is the only trematode in which Plks have
been studied so far. Recently, we have characterized the first
Schistosoma Plk, SmPlk1, and shown that its function is essential for
parasite reproduction. BI2536 (the first-in-class prototype Plk1
inhibitor) inhibited SmPlk1 kinase activity and induced in vitro
dramatic alterations in schistosome gonads, which affected
Figure 3. In situ localization of transcripts in adult worms. In situ hybridization experiments using DIG-labelled antisense- (A–C–E) and sense-
RNA probes (B–D–F) of SmSak. SmSak transcripts were localized mainly in female reproductive organs: vitellarium and ovary in female worms (A–C–E)
and to a lesser extent, in the testes of male worms (A). Scale bars=100 mm (A–B–E–F), 50 mm (C, D). Abbreviations: te, testes; o, ovary; io, immature
ovary; mo, mature ovary; v, vitellarium.
doi:10.1371/journal.pone.0040045.g003
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e40045Figure 4. Analysis of SmSak activity in Xenopus oocytes. A. Constitutively active SmSak induces germinal vesicle breakdown (GVBD) and
meiosis progression in Xenopus oocytes. Different samples of oocytes (n=15) were microinjected with cRNA encoding SmSak, SmSak
DK, SmSakT175D,
SmSakT175D
DK or SmSakT175A. Percentages of oocytes exhibiting GVBD 18 h after microinjection of cRNA are indicated. Non-injected oocytes were
used as control. Western blot analysis of oocyte extracts was performed as described in materials and methods to detect the gel-shift of endogenous
phosphorylated Plx1 and Cdc25C proteins (indicated by arrows). The expression of the different forms of V5-tagged recombinant SmSak was
confirmed by the use of anti-V5 antibodies. B. SmSak mutants do not alter the GVBD induced by progesterone. The experiment was performed as in
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represent a new target against schistosomiasis [23].
Plk1 (Polo in D. melanogaster) [7] is the founding member of the
Plk family that comprises five different members (Plk1-5) in
mammals [4]. Plks are crucial mitotic regulators found in
organisms as diverse as yeast and human. The expansion of the
Plk family from one Plk gene in single cell eukaryotes (cdc5 and
Plo1 in yeasts) [46,47] to five genes in mammals (in mouse and
human) [4], resulted in Plk diversification and likely enabled the
increased complexicity of cell division in animals. Plk4 (also named
Sak for Snk akin kinase) is a unique member of the Plk family,
found in all animals, and in a few other lineages (fungi and ciliates)
[4]. Plk4 has been considered as an odd-one out of the Plk family
[19] since its PBD is formed by one cryptic-polo box and one PB
being quite different from the PBDs of Plk1 and other Plks that are
all formed by a PB tandem. As illustrated in Figure S1, Plk4
originated very likely from a Plk1-like ancestor. Indeed, results of
phylogenetic analyses clearly distinguished the Plk4/Sak subfam-
ily, inside of the Plk family, from the major group composed of
Polo/Plk1 members and Plk2, Plk3 and Plk5 proteins.
Knock-out mice experiments have shown that only Plk1 and
Plk4 were essential for embryonic growth and viability [4]. In the
platyhelminth S. mansoni, only two genes have been found that
encode these two Plks, the previously studied SmPlk1 [23] and the
Plk4 homolog, SmSak. Both schistosome proteins are structurally
similar to their orthologs in other species. No gene coding for Plk2,
Plk3 or Plk5 was detected in the genome of S. mansoni [22], and the
presence of only two Plks in schistosomes corresponds to the
occurrence of only Plk1 and Plk4 homologs in other invertebrates
like the fly D. melanogaster and the nematode C. elegans [4].
However, noticeably, in C. elegans, three different Plk1 proteins
(Plc1, Plc2 and Plc3) are present [48], and the Plk4 homolog is an
atypical Plk4/ZYG-1 protein functionally related to Plk4, but
structurally distinct [49].
Gene exon-intron structure of SmSak (10 exons) was found to
be more complex than that of SmPlk1 (7 exons) [23], but less
complex than that of the murine Sak gene that is formed by 15
exons [50]. It encodes the SmSak protein which has the
conserved structure of Plk4 proteins but also their functional
characteristics. SmSak functions were unravelled by its heterol-
ogous expression in Xenopus oocyte, one of the most appropriate
cellular model to express schistosome proteins [45,51,52] and,
furthermore, to study the function of molecules regulating
mitosis and meiosis [23,28].
SmSak contains a typical Plk kinase domain, characterized by
the unique ATP-binding site GxGxFA sequence present in all Plks
[53]. The essential threonine residue located in the catalytic T
loop of Plks and responsible for their activation [8] is conserved in
SmSak (T175),and we have shown that mimicking the phosphor-
ylation of this threonine (by an aspartate mutation) is sufficient to
induce constitutive activation of SmSak, as it was already
described for SmPlk1 [23]. In Xenopus oocytes, the expression of
SmSakT175D induced oocyte maturation, and this activity was
insensitive to the Plk1-specific inhibitor BI2536 up to 200 nM
(results not shown), while a dose of 20 nM already inhibited 100%
of the activity of SmPlk1T182D in similar conditions [23]. These
data were in agreement with the important structural differences
observed between the kinase domains of SmSak and SmPlk1 (only
37% of identical residues) and confirmed that, in our previous
experiments, gonad alterations in parasites treated in vitro with
BI2536 were effectively the consequences of the specific targeting
of SmPlk1 [23].
In contrast to the Plk4/ZYG1 protein of C. elegans [50], SmSak
contains a conserved Plk4-like PBD formed by one cry-pb and one
PB. Whereas these boxes present a relatively low level of identity
with those of other Plk4/Sak proteins (see Figure S2), we have
been able to show that they can mediate SmSak activation and its
conserved functions in centrosome targeting and centriole
duplication.
PB domains are structural motifs located at the C-terminus of
any Plk. Tandem PB of Plk1-3 proteins can bind to specific
phosphorylated proteins, forming intramolecular heterodimers
that regulate the kinase activity by induction of conformational
changes [8]. In Plk4 proteins, the single PB has been shown to
form homodimers both in vitro and in vivo and this intermolecular
homodimerization is involved in the regulation of kinase activity
and trans-autophosphorylation [14]. Structure-based alignments
of various PB sequences has shown that the PB hydrophobic core
was composed of conserved residues, a large proportion of them
being involved in PB dimer formation [14]. In the SmSak protein,
many of these residue positions are conserved at the dimer
interface (see Figure S2), suggesting that SmSak could also
dimerize to self-activate and to auto-phosphorylate. Indeed, Plk4
autophosphorylation is an essential mechanism by which Plk4
levels are regulated along the cell cycle [18]. Plk4 proteins are
short-lived proteins and their turn-over is achieved by an
autoregulatory process in which the kinase domain autopho-
sphorylates PEST motifs along the molecule, thus allowing its
ubiquitinylation and its targeting to the proteasome for degrada-
tion [19]. A PEST sequence has been found in SmSak located
inside of the PB. Also, the degron motif DSGxxT demonstrated to
be essential for the regulation of Plk4 stability in many species [19]
is relatively well conserved in SmSak and this lets suppose that
SmSak turn-over could be also controlled, as other Plk4 proteins,
by b-TrCP–mediated degradation [26,27,54].
Centrioles organize the formation of microtubule-derived
structures, including cilia and centrosomes [55]. Centriole
duplication needs to be tightly regulated and coordinated with
the cell cycle, because abnormalities in centrosome number and
structure cause genomic instability and cancer [56]. Different
studies have shown that Plk4 is a key regulator of centriole
duplication and required for an accurate reproduction of
centrosomes during the cell cycle [15–18,57]. Plk4 is an
upstream regulator of canonical biogenesis necessary for centriole
A, except that PG was added to the different oocyte groups two hours after microinjection of cRNA preparations. Gel-shifts of Plx1 and Cdc25C are
observed in all oocyte groups associated with high levels of GVBD. C. Endogenous Plx1 is required for the induction of GVBD by SmSakT175D. Oocytes
were injected or not with 5 ng anti-Plx1 antibodies one hour before the injection of 10 or 60 ng SmSak175D cRNA. Meiosis resumption was monitored
as in A and B. SmSakT175D induces GVBD (as already shown in A) following the injection of 60 ng cRNA but has no more effect in Plx1-depleted
oocytes. In control oocytes, it was confirmed that anti-Plk1 antibodies blocked completely the GVBD induced by PG. D. Comparative analysis of the
capacity of SmSak and SmPlk1 to induce GVBD in different conditions. Normal versus Plx1-depleted oocytes were incubated with or without (w/o) PG
following the expression of SmPlk1, SmPlkT182D, SmSak or SmSakT175D. PG stimulates GVBD in the oocytes expressing each of the parasite kinases,
provided that Plx1 is functional in oocytes. In Plx1-depleted oocytes, only SmPlk1 proteins are efficient. In the absence of PG, only constitutively
active kinases are efficient, provided that Plx1 is functional. In Plx1-depleted oocytes, only SmPlkT182D can induce GVBD. These results were
correlated with our previous data [23] and those presented in A, B and C. All percentages of GVBD represent the mean of three independent
experiments. In A, B and C, blots are representative for the three experiments.
doi:10.1371/journal.pone.0040045.g004
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e40045Figure 5. SmSak induces de novo centriole formation in in vitro matured Xenopus oocytes. Samples of cRNA encoding SmSak, SmSakT175A,
SmPlk1 or Kin1-PBD4 and Kin4-PBD1 hybrid proteins, were microinjected in oocytes and incubated for 2 h for protein expression, before addition of
PG. At 15 h following the addition of PG, GVBD monitored by the formation of a white spot centered at the germinal pole of Metaphase II arrested
oocytes, was observed in all oocyte groups. Matured oocytes were then activated with calcium ionophore A23187, and surface morphology was
observed after 30 min or 2 h. Only SmSak-expressing oocytes formed pigmented speckles that increased in number from 30 min to 2 h. In all other
oocytes, the animal pole gradually darkened after the addition of A23187 and the formation of a black spot (fertilization coat) could be seen.
doi:10.1371/journal.pone.0040045.g005
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centrioles in Drosophila embryos but also their de novo formation in
unfertilized Drosophila eggs [34]. More recently, de novo centriole
formation was induced in in vitro-matured oocytes of Xenopus
following overexpression of Plx4 [35]. In this work, we have
analyzed the effects of the expression of the heterologous SmSak
protein in such oocytes and demonstrated that the parasite
protein could exert the same activities as Plx4 for de novo centriole
formation. Expression of a dead-kinase SmSak variant or of
hybrid schistosome Plks (Kin1-PBD4 or Kin4-PBD1) did not
generate the multicentriolar structures observed in oocytes
expressing native SmSak. This indicated that both the kinase
activity and the PBD interaction domains were required for the
capacity of SmSak to induce centriole formation, which
corresponds to previous results obtained for Plx4 [35]. A similar
phenotype observed in Xenopus oocytes overexpressing Plx4 or the
invertebrate SmSak confirmed the functional conservation of
SmSak in centriole biogenesis.
Overall, our studies provide clear evidence that SmSak and
SmPlk1 play distinct roles in cell cycle progression. We have
demonstrated that SmSak, but not SmPlk1, plays a major role
in centriole duplication while SmPlk1, but not SmSak, can
trigger G2/M transition in Xenopus oocytes (Figure 4). These
cells are arrested in G2 of meiosis 1 because they contain
inactive MPF complexes that need to be dephosphorylated by
the phosphatase Cdc25 to allow the entry in M phase. Plx1 (as
all Plk1 proteins including SmPlk1) is a major activator of
Cdc25 and therefore a key inducer of mitosis [28]. The action
of Plx1 is simultaneously dependent on its kinase activity and on
its specific PBD that assures its correct subcellular localization
and substrate interactions [28]. We have clearly confirmed that
SmSak, in contrast to SmPlk1, was not able to induce GVBD in
Plx1-depleted oocytes. Interestingly, we have found that the
hybrid kinase Kin4-PBD1 could perfectly exert the functions of
SmPlk1. One explanation is that the hybrid Kin4-PBD1, which
could be targeted correctly to Plk1 substrates via PBD1,
contained a Kin4 domain able, as Kin1 of SmPlk1, to
phosphorylate Xenopus Cdc25. This hypothesis is in agreement
with published data showing that human Plk4 can phosphor-
ylate and exert an additional control on Cdc25C [58]. This
information, together with the demonstration that SmSak
transcripts, as those of SmPlk1 [23], were abundant in the large
oocytes of the female ovary (ie, in cells that could tentatively be
compared with stage VI Xenopus oocytes arrested at G2 of
Figure 6. Studies of the importance of SmPlk1 and SmSak domains for oocyte maturation by using SmPlk1/SmSak hybrid
constructs. A. Schematic representation of Kin1-PBD4 and Kin4-PBD1 hybrids formed by the fusion of the N-terminal part of SmPlk1 (AA 1–342) with
the C-terminal SmSak (AA 323–618) and that of N-terminal SmSak (AA 1–322) with C-terminal SmPlk1 (AA 343–903), respectively (refer to Figure 1). B.
Different sets of Plx1-depleted oocytes were microinjected with cRNA encoding SmPlk1, SmSak, Kin1-PBD4 or Kin4-PBD1, or their unphosphorylable
variants, and stimulated by the addition of PG. GVBD monitored 18 h after microinjection of cRNA, only occurred in oocytes expressing SmPlk1 and
Kin4-PBD1 that contain phosphorylable T182 and T175, respectively. Western blot analysis of oocyte extracts with anti-V5 antibodies confirmed the
expression of proteins in oocytes. Gel shift of Cdc25 was detected only in matured oocytes.
doi:10.1371/journal.pone.0040045.g006
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participation of SmSak in meiosis resumption, especially via its
possible cooperation with SmPlk1. Surprisingly, we could
demonstrate in this work that the simultaneous expression of
SmSak and SmPlk1 in immature Xenopus oocytes induced
spontaneously GVBD, suggesting that both kinases could
interact and self or cross-activate. An interaction between
SmPlk1 and SmSak was confirmed by co-immunoprecipitation
of both kinases, demonstrating for the first time that Plk1 and
Plk4 proteins have the capacity to interact, and that this
interaction could regulate their activity in cell cycle progression.
Very likely, this interaction is mediated by the respective PBD
of SmPlk1 and SmSak since induction of GVBD also occurred
in the oocytes expressing hybrid constructs (Kin1-PBD4 and
Kin4-PBD1). Further investigations are needed to determine the
specificity of this novel interaction between SmPlk1 and SmSak
proteins in detail. Our results strongly suggest that both SmPlk1
and SmSak kinases should be active in this process since the
expression in Plx1-depleted Xenopus oocytes of unphosphorylable
and thus non-activable SmSak or SmPlk1 had no more effect
on meiosis resumption. Although no precise scheme can be
drawn at this time for the mechanism of kinase activation, this
observation could be of relevance to understand the regulation
of meiosis in schistosomes, and strongly suggested the impor-
tance of SmSak, besides SmPlk1 which has been shown to co-
localize with SmSak in reproductive organs [22,23], in
gametogenesis and parasite reproduction. It would be interesting
to know whether a similar cross-talk between Plk1 and Plk4
proteins could turn out to be a more general phenomenon,
occurring in other animal species. To a larger extent, we could
also conceive that such an activating interaction between these
two major mitotic kinases would have also crucial consequences
in mitosis and cancer for cells in which their expression would
be desynchronized.
In conclusion, we have shown that the second Plk of S. mansoni,
SmSak, possesses the conserved structural and functional proper-
ties of Plk4 proteins and could play a major role in parasite
gametogenesis. The presence of large amounts of SmSak transcripts
in female ovary and vitellarium corroborates previous data in
vertebrates, showing the expression of Plk4 in tissues containing
Figure 7. Interaction between SmPlk1 and SmSak and kinase co-activation. A. Co-immunoprecipitation of SmPlk1 and SmSak expressed in
Xenopus oocytes. Oocytes were injected with V5 tagged-SmPlk1, Myc tagged-SmSak or with both kinases simultaneously. Non-injected oocytes were
used as controls. Following 18 h, GVBD was monitored. Oocyte lysates were prepared and parasite kinases were immunoprecipitated with anti-V5 or
anti-Myc antibodies, then analyzed by western blotting. Results show that immunoprecipitates contained both SmPlk1 and SmSak when the proteins
were co-expressed. B. Co-activation of SmPlk1 and SmSak induces GVBD. In normal or Plx1-depleted oocytes, SmSak was expressed with SmPlk1 or
with SmPlk1T182V and reciproqually SmPlk1 was expressed with SmSak or with SmSak T175A. SmPlk1T182V and SmSakT175A were also expressed
together. Only the co-expression of SmSak and SmPlk1 induced GVBD in normal as well as in Plx1-depleted oocytes. All the other combinations were
inefficient, except the co-expression of SmSak with SmPlk1T182V, that allowed GVBD but only in normal oocytes (containing a functional Plx1).
doi:10.1371/journal.pone.0040045.g007
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appears between the localization of Plk4 in schistosome and
vertebrate tissues. Indeed, SmSak is more expressed in female than
in male reproductive organs whereas mouse Sak [11] and human
Plk4 [13] were detected at the highest level in testes but not in
ovaries, and that mutations in Plk4 caused male hypogonadism
and germ cell loss in mice, suggesting a role for Plk4 in the
initiation of spermatogenesis [59].
Further work is needed to understand precisely the role of
SmSak in gametogenesis but SmSak already appears as a novel
interesting target to combat schistosomiasis, with regard to its
unexpected roles described here in meiosis. An attractive goal of
this study was to confirm a role of SmSak in the development of
reproductive organs and gametogenesis by knocking-down SmSak
by RNA interference (RNAi), an approach already applied with
success for schistosome kinases [29]. However, our different
attempts to knock-down SmSak by RNAi have been unsuccessful,
suggesting that SmSak belongs to the group of non-knockable
genes [60]. Also, at this time, no drug inhibiting specifically the
kinase activity of Plk4 proteins is available. It would be interesting
to pursue the characterization of the kinase domain of SmSak in
order to design specific inhibitors for SmSak and analyze their
effects on parasite fecundity.
Materials and Methods
Ethics Statement
All experiments involving hamsters within this study have been
performed in accordance with the European Convention for the
Protection of Vertebrate Animals used for Experimental and other
Scientific Purposes (ETS No 123; revised Appendix A) and have
been approved by the committee for ethics in animal experimen-
tation of the region Nord Pas de Calais France (authorisation No.
AF/2009) in the local animal house of the Pasteur Institute of Lille
(Agreement No.A59-35009).
Parasite Material
A Puerto-Rican strain of S. mansoni was maintained by passage
through albino Biomphalaria glabrata snails and Mesocricetus auratus
hamsters. Cercariae and schistosomula were prepared as previ-
ously described [61]. Sporocysts were obtained from miracidia
transformed in vitro by incubation in minimum salt medium at
28uC for 18 h [62]. Adult schistosome pairs were collected by
portal perfusion from infected hamsters at 42–45 days p.i. Males
were separated from females with a fine brush.
Cloning of SmSak cDNA
Total RNA was isolated from adult schistosome pairs and
purified by centrifugation through a caesium chloride gradient
[63]. cDNA was prepared using the reverse transcriptase
Thermoscript
TM (Invitrogen). The SmSak sequence was amplified
by PCR using as primers SmSakfwd (59-GCAGATATCATG-
GATGTGGATTATCC-39) and SmSakrev (59-GAGCGGCCG-
CAGAAATAATTTTGTTGGC-39) containing respectively
EcoRV and NotI restriction sites and subcloned into the pCR2.1
TOPO cloning vector (Invitrogen). The full-length sequence of
SmSak was confirmed by sequencing (GATC Biotech).
Sequence Analyses
The genomic database of S. mansoni [24] was screened using the
blastn algorithm (http://blast.ncbi.nlm.nih.gov.gate2.inist.fr/
Blast.cgi) with the SmSak cDNA sequence (GenBank accession
NuGU084154) as a probe, allowing us to determine by eye 59-GT
and 39-AG intron-exon junctions.
Protein sequence analysis of SmSak and alignment with other
Plks were performed using programs included in the Lasergene
package (DNASTAR Inc., Madison, WI, USA). SmSak PEST
motif was found using the ePESTfind server (http://emboss.
bioinformatics.nl/cgi-bin/emboss/epestfind). For phylogenetic
analyses, protein sequences of diverse polo-like kinases were
aligned using ClustalW algorithm (BioEdit). Neighbour joining
tree was then generated with the program MEGA5, using Dayhoff
model and 1000 bootstrap repetitions.
SmSak Plasmid Constructs
SmSak cDNA was cut using EcoRV and NotI restriction sites from
pCR2.1 and inserted in-frame into a V5/His-tagged pcDNA3.1
expression vector (Invitrogen). The SmSak-pcDNA plasmid
construct was used for the production of different mutants using
the QuickChange Site-Directed Mutagenesis Kit (Stratagene)
(according to the procedure described in [23]). A dead kinase
version of SmSak (SmSak
DK) was obtained by replacing the
D160FG162 sequence by a D160NA162 inactive motif using the
primer 59-CAAAATTGCTGACAATGCATTGGCTAC-
TAAAATTG-39 and its reverse complement. Constitutively active
(SmSakT175D) or inactive (SmSakT175A) mutants were generated
using 59-GGTGAAGATCATAAAGACATGTGTGGGA-
CACC-39 and 59-GGTGAAGATCATAAAGCAATGTGTGG-
GACACC-39primers and their reverse complement, respectively
(modified nucleotides are in bold and underlined). A double
mutant (SmSakT175D
DK) was obtained by replacing the DFG
motif by a DNA sequence into the SmSakT175D construct.
Myc-tagged SmSak construct was obtained following the excision
of the SmSak full-length sequence from SmSak pcDNA construct
by EcoRI/NotI double digestion and its further insertion in frame in
pGBKT7 plasmid (Clontech) using the same restriction sites.
SmPlk1/SmSak hybrid proteins were obtained by the bi-
directional exchange of the N terminal (containing the kinase
domain, Kin1 or Kin4) and C terminal (containing PBD1 or
PBD4) parts of SmPlk1 and SmSak, generating Kin1-PBD4 and
Kin4-PBD1 mutants. To facilitate SmPlk1 and SmSak domain
swap, a Not1 restriction site was introduced in each sequence
behind their kinase domains (Kin1 and Kin4 respectively) at
positions corresponding to the residues 322 in SmPlk1 and 342 in
SmSak. Site-directed mutagenesis of SmPlk1-pcDNA [23] and
SmSak-pcDNA plasmids was performed using respectively the
Not1-containing sequences 59-CCTATTACCAGTGGCGG-
CCGCGCCCTTGGTAATG-39 and 59-CCCTTACTTTTTG-
GCGGCCGCACAACCCTTGTC-39 and their reverse comple-
ment as primers. Mutated plasmids were then submitted to a
digestion by NotI and each linearized plasmid as well as NotI/NotI
excised fragments containing respectively PBD1 and PBD4 were
purified, then submitted to a ligation in order to obtain Kin1-
PBD4 and Kin4-PBD1 in-frame sequences.
Protein Expression in Xenopus Oocytes
cRNA encoding wild-type or mutant Plk proteins was synthe-
sised in vitro from pcDNA or pGBKT7 constructs (that contain a
T7 promoter sequence) using the T7mMessage mMachine Kit
(Ambion, USA) following their linearization by PmeI (pcDNA) or
HindIII (pGBKT7) restriction enzymes. cRNA transcribed from
1 mg of linearized plasmid was precipitated by 2.5 M LiCl, washed
in 70% ethanol, resuspended in 20 ml water, then quantified by
spectrophotometry. Finally, 1 mg of cRNA was analysed on a
denaturating agarose gel, stained by ethidium bromide, in order to
confirm the correct size of cRNA and the absence of abortive
transcripts. cRNA solutions (1 mg/ml) were microinjected in stage
VI oocytes of Xenopus laevis according to the protocol previously
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the equatorial region and incubated at 19uC in ND96 medium
(96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2,5m M
HEPES pH 7.4 supplemented with 50 mg/ml streptomycin/
penicillin, 225 mgm l
21 sodium pyruvate, 30 mg/ml trypsin
inhibitor) for 18 h. Germinal vesicle breakdown (GVBD) was
detected by the appearance of a white spot at the centre of the
animal pole. Blocking of endogenous Plx1 activity was performed
by injecting 5 ng (in 25 nl) of anti-Xenopus Plk antibodies (AZ34,
Santa Cruz Biotechnology, Inc., USA) one hour before the
injection of cRNA encoding schistosome Plks or before the
addition of the natural inducer of GVBD, progesterone (PG, 2 mg/
ml).
For experiments of activation and induction of speckled
phenotype, in vitro-matured oocytes which have been previously
treated with PG for 15 h (and which are comparable to
unfertilized eggs at metaphase II) were transferred in ND96
medium previously diluted with 4.8 vol of water and added with
1 mM final concentration of calcium ionophore A23187 (Calbio-
chem). Egg surface morphology was monitored over time under a
binocular microscope.
Western Blot Analyses and Immunoprecipitation
Western blot analyses of total oocyte homogenates were
performed as described previously [64]. Blots were incubated
with anti-V5 antibodies (1/5 000, Invitrogen), anti-Xenopus Plx1
(1/10 000) or anti-Xenopus Cdc25 (1/2 000) antibodies (both sera
were kindly given by A. Kumagai, California Institute of
Technology). Horseradish peroxidase (HRP)-labelled secondary
antibodies were detected using the enhanced chemoluminescence
western blotting detection system (GE Healthcare).
Immunoprecipitation of V5-tagged SmPlk1 and Myc-tagged
SmSak proteins expressed in oocytes was performed according to
the procedure described previously [51]. Following 24 h of
expression, oocytes were lysed in buffer (50 mM HEPES
pH 7.4, 500 mM NaCl, 0.05% SDS, 0.5% Triton X100, 5 mM
MgCl2, 1 mg/ml bovine serum albumin, 10 mg/ml leupeptin,
10 mg/ml aprotinin, 10 mg/ml soybean trypsin inhibitor, 10 mg/
ml benz-amidine, 1 mM PMSF, 1 mM sodium vanadate) and
centrifuged at 4uC for 15 min at 10,000 g. Supernatants were
incubated with anti-V5 or anti-Myc (1/100; Invitrogen) antibodies
overnight at 4uC. Protein A-Sepharose beads (5 mg, Amersham
Biosciences) were added for 1 h at 4uC. Immune complexes were
collected by centrifugation, rinsed three times, resuspended in
Laemmli sample buffer, and subjected to a 10% SDS-PAGE.
Immune complexes were analyzed by Western blotting using anti-
V5 or anti-myc (1/50,000) antibodies and the advanced ECL
detection system (Amersham Biosciences).
Quantitative RT-PCR
Total RNA was isolated from the different stages of S. mansoni
with TRIzolH reagent (Invitrogen) according to the manufacturer’s
instructions. cDNAs were obtained by reverse transcription of total
RNA using the Thermoscript RT-PCR System (Invitrogen) and
used as templates in triplicate assays for PCR amplification using
the SYBRH Green PCR Master Mix and ABI PRISM 7000
sequence detection system (Applied Biosystems) as described
previously [52]. Specific primers for SmSak (nucleotide (nt) 550–
568; 631–651) and SmPlk1 (nt 310–330; 389–410) were designed
by the Primer Express Program (Applied Biosystems). Primers
specific for S. mansoni a-tubulin (GenBank No. M80214, nt 851–
873; 904–925) were used as internal controls. For graphical
representation of qPCR data, DCt (cycle threshold) values (ie Ct
SmSak- Ct Tubulin) were calculated for each parasite stage, and
the DCt value obtained for male worms was deducted from each
value using the delta-delta Ct (DDCt) method [65]. The ratio of
SmSak/SmPlk1 transcripts was expressed for a given parasite
stage by the value of 2
2DCt, where DCt corresponds to the
difference between the Ct value found for SmSak and that found
for SmPlk1 in a given stage.
In situ Hybridization
Adult worm pair sections were prepared and analyzed as
previously described [66]. For hybridization, in vitro sense and
antisense probes of SmSak (nt 2122–2594) were labeled with
digoxigenin following the manufacturer instructions (Roche).
Their size was controlled by gel electrophoresis and digoxigenin
incorporation was confirmed on blots using alkaline phosphatase-
conjugated anti-digoxigenin antibodies (Roche), naphthol-AS-
phosphate, and Fast Red TR (Sigma). In situ hybridizations were
performed for 16 h at 42uC. Parasite sections were stringently
washed up to 0.56SSC (saline salt citrate) and detection of
digoxigenin-labelled transcripts was achieved as described for
blots.
Supporting Information
Figure S1 Phylogenetic analysis of Schistosoma man-
soni polo-like kinases. A. Neighbour joining tree was
generated using MEGA5 under Dayhoff model with 1000
bootstrap repetitions. Bootstrap values are indicated at the nodes.
The scale bar corresponds to 0.2 substitution per site. Protein
sequences of polo-like kinases of Saccharomyces cerevisiae, Schizosac-
charomyces pombe, Caenorhabditis elegans, Drosophila melanogaster, S.
mansoni, Xenopus laevis, Mus musculus and Homo sapiens were analyzed.
B. Protein names and accession numbers are given.
(PDF)
Figure S2 Protein sequence alignment of SmSak with
other Sak/Plk4 kinases. The SmSak sequence was aligned
with that of human hPlk4 (Genbank accession No NP_055079.3),
mouse mSak (AAC37648.1), Plx4 of X. laevis (NP_001083146.1)
and DmSak (AAF51737.1) of D. melanogaster using ClustalW
(DNASTAR Inc., Madison, WI, USA). Shaded areas correspond
to residues which are identical (in black) or similar (in grey) in at
least 75% of the aligned sequences.The serine/threonine kinase
domain (boxed in red) contains the residues required for kinase
activity GxGxFA, HRDLxLxN, DFG and GTPNYIxPE (red
letters). The threonine residue within the T-loop (T175 in SmSak),
whose phosphorylation induces kinase activation, is pointed out by
a blue triangle. The cryptic polo-box (cry-pb) and polo-box (PB)
are boxed respectively in dark and light blue. Amino acids
involved in PB dimerization are indicated with red stars. Finally,
the degron motif responsible for protein degradation [19] and
located just behind the kinase domain is underlined in black.
(PDF)
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